December 31, 2020 at 09:17PM CBER Secure Email Policy Takes Effect October 1, 2018

CBER Secure Email Policy Takes Effect October 1, 2018

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2WYhgtB

December 31, 2020 at 08:44PM 2018 Center for Biologics Evaluation and Research Science Symposium - 06/25/2018 - 06/26/2018

The purpose of the public symposium is to discuss scientific topics related to the regulation of biologics and highlight science conducted at CBER by showcasing how scientific research informs regulatory decision making and to provide a forum for developing collaborations within FDA and with external organizations.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2KOp8uY

December 31, 2020 at 08:13PM 21st US-Japan Cellular and Gene Therapy Conference - 03/01/2018 - 03/01/2018

The goal of the annual US-Japan cellular and gene therapy conference is to exchange ideas on cutting edge and diverse areas of biomedical research, and enhance opportunities for collaborations among scientists from the US and Japan.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/382yVGy

December 31, 2020 at 08:06PM Workshops, Meetings & Conferences (Biologics)

Information on CBER sponsored or co-sponsored meetings, conferences and workshops about various biologics in order to educate the public and seek the opinion of interested parties.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2XKPH9W

December 31, 2020 at 04:38PM Roster of the Vaccines and Related Biological Products Advisory Committee

This is the Roster of the Vaccines and Related Biological Products Advisory Committee

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2LdRQ7c

December 31, 2020 at 03:39PM FDA Voices on Policy

FDA Voices on Policy

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2wZLu61

December 30, 2020 at 08:56PM 2020 at FDA: A Year of Unparalleled Contributions to Public Health

2020 has been a year like no other in recent memory for public health and FDA.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2WV9gcu

December 30, 2020 at 06:06PM Developing and Manufacturing Drugs Including Biologics

This material is intended to be a helpful resource that consolidates information relevant for drug manufacturers making products for the U.S. market. It is not a comprehensive list of all applicable statutory and regulatory requirements.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/31wAKrK

December 29, 2020 at 05:42PM Application Submissions Guidances

This page lists Application Submissions Guidance documents.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2JCweiX

December 28, 2020 at 08:15PM Adacel

Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2YSVdV1

December 28, 2020 at 11:43PM Coronavirus (COVID-19) Update: December 28, 2020

Coronavirus (COVID-19) Update

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2Jq1wfA

December 23, 2020 at 12:08AM Coronavirus (COVID-19) Update: December 22, 2020

Coronavirus (COVID-19) Update

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2WHv9Mg

December 22, 2020 at 09:08PM Strong Fertility Center - 593262 - 12/11/2020

Deviations/CFR/Regulations for Human Cells, Tissues & Cellular Products (HCT/Ps)

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2LWYxfv

December 22, 2020 at 09:06PM Strong Fertility Center - 593262 - 10/29/2019

Deviations/CFR/Regulations for Human Cells, Tissues & Cellular Products (HCT/Ps)

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2CzDTKw

December 22, 2020 at 09:05PM Pandemic Influenza Information

Pandemic influenza (flu) is a significant global public health threat. Preparedness has been recognized as a critical local, national and worldwide priority

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3papWZI

December 22, 2020 at 08:25PM Smallpox

Smallpox is a serious, highly contagious, and sometimes fatal infectious disease. There is no specific treatment for smallpox disease, and the only prevention is vaccination. The name is derived from the Latin word for "spotted" and refers to the raised bumps that appear on the face and body of an infected person.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/34TeYAn

December 22, 2020 at 07:59PM Anthrax

Anthrax is an infectious disease caused by spores of the bacterium, Bacillus anthracis. CBER continues to work with multiple manufacturers in the development of immune globulins as a potential treatment for anthrax infection.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3hbfRZH

December 22, 2020 at 06:45PM Effects of the COVID-19 Public Health Emergency on Formal Meetings and User Fee Applications for Medical Devices - Questions and Answers (Revised)

FDA is issuing this guidance to provide clarity on meetings and user fees during the COVID-19 public health emergency.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2NjQua3

Monday, December 21, 2020

December 22, 2020 at 12:25AM Coronavirus (COVID-19) Update: December 21, 2020

Coronavirus (COVID-19) Update

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3h5lqsM

December 21, 2020 at 07:53PM Review Timelines for Applicant Responses to Complete Response Letters When a Facility Assessment Is Needed During the COVID-19 Public Health Emergency Guidance for Industry

Review Timelines for Applicant Responses to Complete Response Letters When a Facility Assessment Is Needed During the COVID-19 Public Health Emergency Guidance for Industry

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3mGO2cZ

December 21, 2020 at 06:28PM Recommendations for the Use of Vaccines Manufactured with Bovine-Derived Materials

Recommendations for the Use of Vaccines Manufactured with Bovine-Derived Materials

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3nGfAAD

December 21, 2020 at 04:38PM Vaccine Safety Questions and Answers

Questions and answers on vaccine safety.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2KFK72O

December 21, 2020 at 04:08PM Influenza Virus Vaccine Safety & Availability

Influenza (flu) is a contagious respiratory disease that is caused by influenza viruses. Influenza viruses infect the respiratory tract (nose, throat, and lungs) in humans.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2Ha4AHV

Friday, December 18, 2020

December 19, 2020 at 01:46AM Moderna COVID-19 Vaccine

Information about the Moderna COVID-19 Vaccine

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3rlqM82

December 19, 2020 at 01:29AM FDA Takes Additional Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for Second COVID-19 Vaccine

Today, the FDA issued an emergency use authorization (EUA) for the second vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The vaccine is for use in individuals 18 years of age and older.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3nz2u8d

December 18, 2020 at 10:34PM Vaccine Safety & Availability

Vaccine Safety & Availability

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2MhqCNq

December 18, 2020 at 05:55PM Vaccine Adverse Events

Information about the Vaccine Adverse Event Reporting System (VAERS), which is a national vaccine safety surveillance program co-sponsored by the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) to detect possible signals of adverse events associated with vaccines.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/32dXLAC

December 18, 2020 at 07:03PM Use of Fecal Microbiota for Transplantation (FMT) to Treat Clostridium difficile Infection Not Responsive to Standard Therapies - 11/04/2019 - 11/04/2019

The purpose of the public hearing is to obtain public input on the state of the science regarding FMT to treat C. difficile infection not responsive to standard therapies, including the available clinical evidence for safety and effectiveness of FMT for this use and to better understand the impact of FDA’s enforcement policy on product development.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2nRff4k

December 18, 2020 at 02:15PM Consumer Updates

Science-based health and safety information you can trust.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/31VUzHA

Thursday, December 17, 2020

December 18, 2020 at 02:36AM FDA Statement on Vaccines and Related Biological Products Advisory Committee Meeting

FDA Statement on Vaccines and Related Biological Products Advisory Committee Meeting

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2IYUNsM

December 18, 2020 at 12:24AM Coronavirus (COVID-19) Update: December 17, 2020

Coronavirus (COVID-19) Update

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3myYset

December 17, 2020 at 10:07PM 23rd US-Japan Cellular and Gene Therapy Conference - 03/12/2020 - 03/12/2020

The annual US-Japan Cellular and Gene Therapy Conference will provide scientists from Japan and the U.S. a valuable opportunity to discuss the state of the art of exosome therapies and establish research collaborations.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/39HvS4X

December 17, 2020 at 10:01PM Considerations for the Use of Real-World Evidence to Assess the Effectiveness of Preventive Vaccines - 09/17/2020 - 09/18/2020

The purpose of this online symposium is to exchange information with stakeholders from industry, academia, and government about the scientific, clinical, and regulatory challenges and opportunities in using RWE to assess the effectiveness of preventive vaccines.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2CIVK4S

December 17, 2020 at 09:07PM Bacterial Risk Control Strategies for Blood Collection Establishments and Transfusion Services to Enhance the Safety and Availability of Platelets for Transfusion

This is the Guidance for industry, Bacterial Risk Control Strategies for Blood Collection Establishments and Transfusion Services to Enhance the Safety and Availability of Platelets for Transfusion. - Updated December 2020

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2nVjQlu

December 17, 2020 at 07:03PM Section 8400: Marketing Applications

This is the SOPP Section 8400: Marketing Applications main page.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2U9zYMz

December 17, 2020 at 02:43PM Vaccines Licensed for Use in the United States

The product name and trade name of vaccines licensed for use in the United States.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/35IEpCG

December 17, 2020 at 04:47PM Vaccine EUA Questions and Answers for Stakeholders

Questions and answers about vaccine Emergency Use Authorizations for stakeholders including industry, health care providers, pharmacists, and state, local, tribal, and territorial governments

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2Kx4rU7

December 17, 2020 at 04:01PM Pfizer-BioNTech COVID-19 Vaccine Frequently Asked Questions

Answers to frequently asked questions about the Emergency Use Authorization of the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/34jUUa0

Wednesday, December 16, 2020

December 17, 2020 at 12:18AM Coronavirus (COVID-19) Update: December 16, 2020

Coronavirus (COVID-19) Update

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2K9LFlC

December 16, 2020 at 10:31PM Quantitation of AAV-Based Gene Therapy Products - 12/07/2018 - 12/07/2018

The purpose of the public workshop is to discuss best practices when measuring the concentration of AAV vectors and to provide FDA perspective on qualifying such assays. The public workshop will bring together academia, industry, and other stakeholders involved in research, development, and regulation of AAV-Based gene therapy products.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/37nDefu

December 16, 2020 at 09:56PM Developing Predictive Indicators of Genome Stability and Cell Maturation as Measures of Cell Therapy Product Safety and Efficacy

A description of Deborah Hursh's research program and related publications.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3p5buCt

December 15, 2020 at 08:55PM Interacting with the FDA on Complex Innovative Trial Designs for Drugs and Biological Products

This the Guidance for Industry, Interacting with the FDA on Complex Innovative Trial Designs for Drugs and Biological Products, Level 1, CBER, CDER, Biologics, Drugs, December 2020

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2M6ENT4

Tuesday, December 15, 2020

December 15, 2020 at 10:39PM Tissue & Advanced Therapies Research

This page is about Tissue & Advanced Therapies Research

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2B4RpYX

December 15, 2020 at 06:59PM Guidance Recap Podcast: Interacting with the FDA on Complex Innovative Trial Designs for Drugs and Biological Products Podcast

The Guidance Recap Podcast provides highlights for FDA guidance documents straight from the authors.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3frxJx9

December 15, 2020 at 07:58PM Toward More Effective Treatment of Blood Clotting Disorders: Pharmacogenomic Studies of ADAMTS13 and Related Proteins

A description of Chava Kimchi-Sarfaty's research program and related publications.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/34yrjIx

December 15, 2020 at 07:07PM Developing Ways to Measure Safety and Efficacy for Tissue-engineered Products

A description of Brenton McCright's research program and related publications.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3noNZn8

Monday, December 14, 2020

December 15, 2020 at 12:34AM Coronavirus (COVID-19) Update: December 14, 2020

Coronavirus (COVID-19) Update

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/37h8uMX

December 14, 2020 at 10:02PM Questions about Vaccines

Information on general and specific vaccines

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2Wi4wxk

December 14, 2020 at 08:50PM Resources Related to Regenerative Medicine Therapies

Information on FDA’s Framework for the Regulation of Regenerative Medicine Products


via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/35Ldpm5

December 14, 2020 at 08:00PM Help Stop the Spread of Coronavirus and Protect Your Family

We can each help slow the spread of coronavirus disease and protect ourselves, our families and our communities. Wash your hands often with soap and water; cover your mouth and nose with a cloth face covering or non-surgical mask when around others; 3) avoid crowds and practice social distancing.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/33Z5W4O

December 14, 2020 at 02:12PM Measles, Mumps and Rubella Virus Vaccine Live

Product approval information for the Measles, Mumps, and Rubella Virus Vaccine, Live also known as M-M-R II.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2QmZpuc

Friday, December 11, 2020

December 12, 2020 at 03:55AM Pfizer-BioNTech COVID-19 Vaccine

Information about the Pfizer-BioNTech COVID-19 vaccine

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3774pem

December 12, 2020 at 03:32AM FDA Takes Key Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for First COVID-19 Vaccine

Today, the FDA issued the first emergency use authorization (EUA) for a vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 16 years of age and older.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3qKlrH7

December 11, 2020 at 10:25PM Therapeutic Cloning and Genome Modification

The rapid advances over the past few decades in biotechnologies involving somatic cells and gene therapy offer a great potential in regenerative medicine and for the treatment of genetic defects.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/37SZxbX

December 11, 2020 at 12:53PM FDA Statement on Vaccines and Related Biological Products Advisory Committee Meeting

FDA Statement on Vaccines and Related Biological Products Advisory Committee Meeting

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3maWhO2

Thursday, December 10, 2020

December 10, 2020 at 11:50PM Coronavirus (COVID-19) Update: December 10, 2020

Coronavirus (COVID-19) Update

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/37NbnEs

December 10, 2020 at 08:08PM Developing Predictive Indicators of Cell Maturation as Measures of Cell Therapy Product Efficacy and Safety

A description of Deborah Hursh's research program and related publications.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2Z0vaMi

December 10, 2020 at 03:21PM Coronavirus (COVID-19) Update: FDA Holds Advisory Committee Meeting to Discuss Authorization of COVID-19 Vaccine Candidate as Part of Agency’s Review of Safety and Effectiveness Data

Today, the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) is meeting to discuss the first request for emergency use authorization for a vaccine for COVID-19 prevention, submitted by Pfizer Inc. in partnership with BioNTech Manufacturing GmbH.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3gAqPaN

Wednesday, December 9, 2020

December 09, 2020 at 11:07PM Cell-specific And Gene-specific Targeting of Gene Therapy Vectors

A description of Jakob Reiser's research program and related publications.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3gAdlMj

December 09, 2020 at 09:12PM Approved Cellular and Gene Therapy Products

Listing of licensed and approved products from the Office of Tissues and Advanced Therapies (OTAT).

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/39nXywG

December 09, 2020 at 03:12PM Remarks by Dr. Hahn for the Reagan-Udall Foundation's Innovation in Regulatory Science Awards - 12/08/2020

Remarks by Stephen Hahn, MD, Reagan-Udall Foundation for the FDA, Innovation in Regulatory Science Awards, December 8

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2VVtnaj

Tuesday, December 8, 2020

December 09, 2020 at 12:20AM Coronavirus (COVID-19) Update: December 8, 2020

Coronavirus (COVID-19) Update

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/33VmLNz

December 08, 2020 at 10:26PM Testing Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/P): Specific Requirements

These are the Specific Requirements for Testing Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/P)

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2C2DrYo

December 07, 2020 at 08:07PM Remarks by Dr. Hahn to the National Academy of Medicine Town Hall on the COVID-19 Vaccine - 12/04/2020

Remarks by Stephen. Hahn, MD, Commissioner of Food and Drugs, The National Academy of Medicine Town Hall on the COVID-19 Vaccine, Dec. 4, 2020

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2VRcSf6

December 07, 2020 at 07:23PM FDALabel: Full-Text Search of Drug Labeling

FDALabel Database is a web-based application that allows users to perform customizable searches of a database containing over 100,000 drug labeling documents for FDA-approved drug products, including human and animal prescription and over-the-counter drugs, biological products, and medical devices.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2mKOnlw

December 07, 2020 at 05:15PM Remarks by Dr. Hahn to the FDA-CMS Summit - 12/07/2020

Remarks by Stephen Hahn, MD, Commissioner of Food and Drugs, FDA-CMS Summit, December 7

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2Is4lfM

Friday, December 4, 2020

December 04, 2020 at 09:32PM Compliance Actions (Biologics)

CBER carries out a wide range of compliance and surveillance activities during the "life cycle" of biological products

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/30gX6gn

December 04, 2020 at 09:27PM Healthcare Providers (Biologics)

Resources for Healthcare Providers on biological products.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3lHEuOt

December 04, 2020 at 09:22PM Industry (Biologics)

CBER’s Manufacturers Assistance and Technical Training Branch provides assistance and training to industry, including large and small manufacturers and trade associations, and to respond to requests for information regarding CBER policies and procedures.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2QSlekD

December 04, 2020 at 09:13PM Tissue Guidances

This page contains a listing of tissue related guidances.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2MeJ6ww

December 04, 2020 at 09:11PM Vaccine and Related Biological Product Guidances

This page contains a listing of vaccine and related biological product guidances

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2Mm0pfA

December 04, 2020 at 07:56PM Remarks by Dr. Hahn to the Remarks to the National Academy of Medicine Town Hall on the COVID-19 Vaccine - 12/04/2020

Remarks by Stephen. Hahn, MD, Commissioner of Food and Drugs, The National Academy of Medicine Town Hall on the COVID-19 Vaccine, Dec. 4, 2020

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/33JiIDP

December 04, 2020 at 06:05PM FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Public Health Emergency

FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic | Guidance for Industry, Investigators, and Institutional Review Boards

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2XHJYR1

Thursday, December 3, 2020

November 30, 2020 at 04:20PM Why the United States-Mexico-Canada Agreement is Important to FDA

How the many provisions in the United States-Mexico-Canada Agreement affect FDA, advance public health and FDA’s regulatory approaches.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3mG3DdE

December 02, 2020 at 12:47AM Requesting FDA Feedback on Combination Products

Final guidance for industry and FDA staff: Requesting FDA Feedback on Combination Products

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/395u9H0

December 03, 2020 at 01:42PM Vaccines and Related Biological Products Advisory Committee December 17, 2020 Meeting Announcement - 12/17/2020 - 12/17/2020

This is the CBER Vaccines and Related Biological Products Advisory Committee December 17, 2020 Meeting Announcement.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2JEfuuf

December 02, 2020 at 11:26PM Select CBER Projects and Activities

CBER projects and activities that address the 21st Century Cures Act and the Prescription Drug User Fees Act VI Reauthorization (PDUFA VI) as authorized by the FDA Reauthorization Act (FDARA)

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2UYjuqT

December 02, 2020 at 04:17PM Recommendations for Screening, Testing, and Management of Blood Donors and Blood and Blood Components Based on Screening Tests for Syphilis

This is the Recommendations for Screening, Testing, and Management of Blood Donors and Blood and Blood Components Based on Screening Tests for Syphilis; Guidance for Industry.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/36ycAQJ

Tuesday, December 1, 2020

December 02, 2020 at 01:08AM Coronavirus (COVID-19) Update: December 1, 2020

Coronavirus (COVID-19) Update

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3lnQIvq

December 01, 2020 at 02:44PM FDA Voices on Medical Products

FDA Voices on Medical Products

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3fPjV0W